William Newell named CEO of Sutro Biopharma
This article was originally published in Scrip
Executive Summary
The US biopharmaceutical company Sutro Biopharma (formerly known as Fundamental Applied Biology) has appointed William Newell chief executive officer. The company's former CEO, Dr Daniel Gold, becomes president and chief operating officer. Mr Newell has more than 10 years' experience in the biotechnology industry, having previously served as president of Aerovance, chief business officer of QLT and senior vice-president of corporate and business development at Celera Genomics.